You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radiographic progression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peri-Implant Disease Progression: A Prospective Study

Recruiting
  • Peri-Implantitis
  • Bleeding of Subgingival Space
  • Clinical measurements
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh School of Dental Medicine
Sep 5, 2023

Ankylosing Spondylitis Trial in Worldwide (Secukinumab, GP2017 (adalimumab biosimilar))

Completed
  • Ankylosing Spondylitis
  • Secukinumab
  • GP2017 (adalimumab biosimilar)
  • Mesa, Arizona
  • +169 more
Sep 9, 2022

Metastatic Castration-Sensitive Prostate Cancer Trial in Worldwide (AZD5305, Placebo, Abiraterone Acetate)

Not yet recruiting
  • Metastatic Castration-Sensitive Prostate Cancer
  • Tucson, Arizona
  • +192 more
Nov 6, 2023

Chinese Spondyloarthritis Inception Cohort (CESPIC)

Not yet recruiting
  • Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)
  • +6 more
  • (no location specified)
Jul 25, 2023

Metastatic Breast Cancer Trial in Worldwide (Enobosarm, Exemestane)

Recruiting
  • Metastatic Breast Cancer
  • Anchorage, Alaska
  • +58 more
Jan 6, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 23, 2023

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Nanjing (6-month course of antiandrogen drugs, Long-term course of

Recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  • 6-month course of antiandrogen drugs
  • Long-term course of antiandrogen drugs
  • Nanjing, Jiangsu, China
    Urology dpt, First Affiliated Hospital of Nanjing Medical Univer
Jul 13, 2023

Metastatic Castration-resistant Prostate Cancer, Androgen Resistant Prostatic Cancer Trial in United States (VERU-111,

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Androgen Resistant Prostatic Cancer
  • Anchorage, Alaska
  • +43 more
Jan 3, 2023

Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore

Recruiting
  • Prostate Cancer
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Hospital
May 6, 2022

Prostate Cancer Trial (Dutasteride, Abiraterone)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
Jan 30, 2023

Castration-resistant Prostate Cancer, Metastatic Cancer, Prostate Cancer Trial in Saint Louis, Madison (pTVG-HP, pTVG-AR,

Recruiting
  • Castration-resistant Prostate Cancer
  • +2 more
  • pTVG-HP
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Nov 21, 2022

Prostate Cancer Metastatic, Prostate Cancer Trial in Worldwide (ODM-201, Placebo)

Active, not recruiting
  • Prostate Cancer Metastatic
  • Prostate Cancer
  • Bordeaux, France
  • +31 more
Mar 18, 2022

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Nov 28, 2022

NSCLC, Stage III Trial in Indianapolis (Signatera ctDNA test)

Not yet recruiting
  • NSCLC, Stage III
  • Signatera ctDNA test
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Mar 13, 2023

Metastatic Castration-resistant Prostate Cancer Trial (ONC-392, lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • ONC-392
  • lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV infusion, Q6W for up to 6 doses.
  • (no location specified)
Dec 27, 2022

Prostate Cancer Metastatic Trial (MK-5684, Abiraterone acetate, Enzalutamide)

Not yet recruiting
  • Prostate Cancer Metastatic
  • (no location specified)
Nov 21, 2023

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • Prostatic Neoplasms
  • (no location specified)
Nov 21, 2023

Dental Caries Trial in Talca (Self-etching Adhesive, Glass Ionomer)

Completed
  • Dental Caries
  • Self-etching Adhesive
  • Glass Ionomer
  • Talca, No State, Chile
    Faculty of Health Sciences
Dec 26, 2022

Metastatic Hormone-Sensitive Prostate Cancer Trial in China (biological, drug, procedure, other)

Active, not recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer
  • Pembrolizumab
  • +3 more
  • Beijing, Beijing, China
  • +23 more
Sep 30, 2022

Castration-resistant Prostate Cancer Trial in Los Angeles (Apalutamide, Carotuximab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Los Angeles, California
    Cedars-Sinai Medical Center
Sep 6, 2022

Metastatic Hormone Sensitive Prostate Cancer Trial in Worldwide (Enzalutamide, Placebo)

Active, not recruiting
Has Results
  • Metastatic Hormone Sensitive Prostate Cancer
  • Homewood, Alabama
  • +202 more
Jul 29, 2022

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Cancer Trial in Tampa (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023

Analysis of Radiographic and Kinematic Features in FAI Patients

Completed
  • Femoro Acetabular Impingement
    • Beijing, China
      Peking University Third Hospital
    May 17, 2023

    Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

    Not yet recruiting
    • Metastatic Hormone-Sensitive Prostate Cancer
    • (no location specified)
    Nov 10, 2023

    Prostate Cancer Trial in United States (Cabazitaxel, Carboplatin, Abiraterone)

    Recruiting
    • Prostate Cancer
    • Phoenix, Arizona
    • +7 more
    Apr 12, 2022